Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats

Epilepsia
Erwin A van VlietJan A Gorter

Abstract

Overexpression of multidrug transporters such as P-glycoprotein (P-gp) may play a significant role in pharmacoresistance, by preventing antiepileptic drugs (AEDs) from reaching their targets in the brain. Until now, many studies have described increased P-gp expression in epileptic tissue or have shown that several AEDs act as substrates for P-gp. However, definitive proof showing the functional involvement of P-gp in pharmacoresistance is still lacking. Here we tested whether P-gp contributes to pharmacoresistance to phenytoin (PHT) by using a specific P-gp inhibitor in a model of spontaneous seizures in rats. The effects of PHT on spontaneous seizure activity were investigated in the electrical post-status epilepticus rat model for temporal lobe epilepsy, before and after administration of tariquidar (TQD), a selective inhibitor of P-gp. A 7-day treatment with therapeutic doses of PHT suppressed spontaneous seizure activity in rats, but only partially. However, an almost complete control of seizures by PHT (93 +/- 7%) was obtained in all rats when PHT was coadministered with TQD. This specific P-gp inhibitor was effective in improving the anticonvulsive action of PHT during the first 3-4 days of the treatment. Western blot an...Continue Reading

References

Oct 1, 1985·Analytical Biochemistry·P K SmithD C Klenk
Oct 8, 1999·British Journal of Pharmacology·C MartinR Callaghan
Feb 5, 2000·The New England Journal of Medicine·P Kwan, M J Brodie
Apr 20, 2000·Epilepsy Research·W LöscherU Ebert
Feb 24, 2001·Lancet·S M SisodiyaM Thom
Mar 1, 2003·Epilepsy & Behavior : E&B·Graeme J. SillsMartin J. Brodie
Mar 29, 2003·The Journal of Pharmacology and Experimental Therapeutics·Heidrun PotschkaWolfgang Löscher
Apr 25, 2003·Cancer Control : Journal of the Moffitt Cancer Center·Hilary Thomas, Helen M Coley
Sep 26, 2003·Cancer·Sharon H Giordano
Dec 6, 2003·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·G IlbayN Ates
Aug 26, 2004·The Annals of Pharmacotherapy·Monica A SummersJames W McAuley
Nov 16, 2004·Epilepsy Research·Wolfgang Löscher, Dieter Schmidt
Jun 11, 2005·Epilepsia·Dieter Schmidt, Wolfgang Löscher

❮ Previous
Next ❯

Citations

Apr 1, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Francesco NoéAnnamaria Vezzani
Jun 6, 2007·Nature Clinical Practice. Neurology·Sanjay Sisodiya
Jan 1, 2010·Nature Reviews. Drug Discovery·Meir Bialer, H Steve White
Jan 26, 2008·The Neurologist·Juan Carlos Sánchez AlvarezJosé María Serratosa Fernández
Feb 24, 2007·Epilepsia·Wolfgang Löscher
Feb 13, 2008·Epilepsia·Michelle HildebrandtIngmar Blümcke
Feb 13, 2008·Epilepsia·Erwin A van VlietJan A Gorter
Jul 17, 2008·Epilepsia·Wolfgang LöscherDieter Schmidt
Jan 12, 2011·Epilepsia·Melanie JambroszykHeidrun Potschka
May 8, 2009·Epilepsy Currents·Dieter Schmidt, Wolfgang Löscher
Sep 25, 2012·Journal of Veterinary Internal Medicine·K R MuñanaK L Mealey
Jul 14, 2011·Indian Journal of Human Genetics·Abhijit DasKurupath Radhakrishnan
Aug 26, 2014·International Journal of Nanomedicine·Jian-Sheng LiuZhen Hong
May 20, 2009·Pharmacogenomics·Dalia Kasperaviciūte, Sanjay M Sisodiya
Dec 1, 2009·Future Medicinal Chemistry·David D StenehjemGrant W Anderson
Mar 14, 2007·Current Opinion in Neurology·Ettore Beghi
Apr 13, 2007·Expert Review of Anticancer Therapy·Elizabeth Fox, Susan E Bates
May 29, 2008·Expert Review of Neurotherapeutics·Christian BrognaHugues Duffau
Jul 7, 2011·Expert Opinion on Drug Discovery·Detlev BoisonJonathan D Geiger
Mar 14, 2013·Expert Opinion on Medical Diagnostics·Clarissa Lin Yasuda, Fernando Cendes
May 10, 2013·Journal of Pharmaceutical Sciences·Ming-Liang LaiJin-Ding Huang
Jul 11, 2007·Journal of Pharmaceutical Sciences·Ivan O EdafioghoK R Scott
Apr 30, 2015·Epilepsy & Behavior : E&B·Jacqueline A FrenchRoger Porter
Jan 23, 2014·Epilepsia·Asheebo RojasRaymond Dingledine
Dec 27, 2011·Advanced Drug Delivery Reviews·Chunbo ZhangLarry Baum
Dec 6, 2011·Advanced Drug Delivery Reviews·Eleonora AronicaJan A Gorter
Jun 7, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Prasad NeeratiSathish Kumar Bedada
May 24, 2011·Toxicology Letters·Marloes J A JoosenHerman P M van Helden

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.